These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31272582)

  • 1. Identification of a Novel ZBTB20-JAK2 Fusion by Mate-Pair Sequencing in a Young Adult With B-Lymphoblastic Leukemia/Lymphoma.
    Peterson JF; Blackburn PR; Webley MR; Pearce KE; Williamson CM; Vasmatzis G; Smadbeck JB; Bieliauskas SL; Reichard KK; Ketterling RP; Baughn LB; Greipp PT
    Mayo Clin Proc; 2019 Jul; 94(7):1381-1384. PubMed ID: 31272582
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and
    Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.
    Mayfield JR; Czuchlewski DR; Gale JM; Matlawska-Wasowska K; Vasef MA; Nickl C; Pickett G; Ness SA; Winter SS
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27860260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility.
    Lin M; Nebral K; Gertzen CGW; Ganmore I; Haas OA; Bhatia S; Fischer U; Kuhlen M; Gohlke H; Izraeli S; Trka J; Hu J; Borkhardt A; Hauer J; Auer F
    Leukemia; 2019 Sep; 33(9):2331-2335. PubMed ID: 30967616
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).
    Kawamura M; Taki T; Kaku H; Ohki K; Hayashi Y
    Genes Chromosomes Cancer; 2015 Jul; 54(7):401-8. PubMed ID: 25951811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis.
    Roll JD; Reuther GW
    Cancer Res; 2010 Oct; 70(19):7347-52. PubMed ID: 20807819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RNPC3 as a novel JAK2 fusion partner gene in B-acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib.
    Chen X; Wang F; Zhang Y; Ma X; Liu M; Cao P; Zhou L; Wang L; Zhang X; Wang T; Liu H
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1110. PubMed ID: 31885183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.
    Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC
    Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia.
    Downes CEJ; Rehn J; Heatley SL; Yeung D; McClure BJ; White DL
    Br J Haematol; 2022 Feb; 196(3):700-705. PubMed ID: 34697799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
    Yano M; Imamura T; Asai D; Kiyokawa N; Nakabayashi K; Matsumoto K; Deguchi T; Hashii Y; Honda YK; Hasegawa D; Sasahara Y; Ishii M; Kosaka Y; Kato K; Shima M; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K; Ichikawa H; Sato A
    Br J Haematol; 2015 Dec; 171(5):813-7. PubMed ID: 26404892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.
    Chapiro E; Russell L; Lainey E; Kaltenbach S; Ragu C; Della-Valle V; Hanssens K; Macintyre EA; Radford-Weiss I; Delabesse E; Cavé H; Mercher T; Harrison CJ; Nguyen-Khac F; Dubreuil P; Bernard OA
    Leukemia; 2010 Mar; 24(3):642-5. PubMed ID: 19907440
    [No Abstract]   [Full Text] [Related]  

  • 12. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
    Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
    Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of E627 and R683 interaction is responsible for B-cell acute lymphoblastic leukemia caused by JAK2 R683G(S) mutations.
    Wu QY; Guo HY; Li F; Li ZY; Zeng LY; Xu KL
    Leuk Lymphoma; 2013 Dec; 54(12):2693-700. PubMed ID: 23452118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability.
    Li F; Guo HY; Wang M; Geng HL; Bian MR; Cao J; Chen C; Zeng LY; Wang XY; Wu QY
    Int J Biol Macromol; 2013 Sep; 60():186-95. PubMed ID: 23748007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ph-like B-cell acute lymphoblastic leukemia with ZEB2-JAK2 fusion gene positivity: a case report].
    Shen K; Wang M; Hu DY; Guo YS; Chen SN
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):606. PubMed ID: 37749046
    [No Abstract]   [Full Text] [Related]  

  • 16. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
    Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
    Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
    Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
    Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
    Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
    Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
    [No Abstract]   [Full Text] [Related]  

  • 20. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
    Miyamoto N; Sugita K; Goi K; Inukai T; Lijima K; Tezuka T; Kojika S; Nakamura M; Kagami K; Nakazawa S
    Leukemia; 2001 Nov; 15(11):1758-68. PubMed ID: 11681418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.